This Week in Cannabis: March 13, 2026
This week’s roundup covers marijuana reclassification drug testing impacts and recent clinical cannabis research. Key studies on cannabinoids for insomnia and anxiety highlight mixed outcomes. Regulatory updates and synthetic opioid scheduling also shape…
Cannabis Medicine Regulations 2026: Key Updates March 13
This update covers cannabis medicine regulations 2026, highlighting key controlled substances scheduling and Medicare policy changes. These regulatory updates impact clinical research and patient access. Cannabis clinicians should stay informed on…
Cannabinoid Clinical Trials: Cannabis Dosing for Insomnia
This article reviews cannabinoid clinical trials insomnia research, highlighting a pilot study on cannabis dosing effects. The trial examined THC and CBD impact on sleep architecture in insomnia patients. Findings emphasize the need for objective sleep…
Outcomes of Cannabis Use in Trauma-Focused PTSD and SUD Treatment
This article reviews cannabis use trauma-focused treatment PTSD SUD outcomes in patients with co-occurring disorders. Evidence shows trauma-focused treatments remain effective despite cannabis use. Clinicians should consider these outcomes when planning…
Cannabinoids for Children: Evidence-Based Clinical Review
Cannabinoids pediatric medical conditions have been studied extensively with over 270 clinical trials and observational reports. Evidence suggests potential benefits in select pediatric conditions, though quality varies. Clinicians must weigh benefits…
New Hampshire House Lets Marijuana Legalization And Psilocybin Therapy Bills Die Without A Vote
The failure to advance psilocybin therapy legislation in New Hampshire delays potential clinical pathways for treating treatment-resistant depression and PTSD. This legislative inaction maintains the state's prohibition on recreational cannabis and…
A Beginner’s Guide to Reading Cannabis Certificates of Analysis in Florida
Understanding the certificate of analysis cannabis Florida documents is essential for clinicians and patients. These certificates provide detailed cannabinoid content and contaminant testing results. Proper interpretation helps guide safe and effective…
Medical Cannabis Dispensary Network Expansion Insights
This article discusses the medical cannabis dispensary network expansion and its impact on clinical practice. The focus on regulated cannabis programs highlights growing acceptance in healthcare. Medical cannabis dispensary network expansion is key to…
Marijuana Rescheduling Is A ‘Transitional’ Step That Must Be Followed By Banking Reform
Marijuana rescheduling banking reform is a critical transitional step following federal cannabis rescheduling to Schedule III. This reform will facilitate research and improve financial access for cannabis businesses. Without banking reform, the cannabis…
CMMNJ Endorses A1291 to Improve Cannabis Product Testing in NJ
Strengthened cannabis product testing requirements are essential for reducing patient exposure to contaminants and mislabeled potency. These requirements ensure safer cannabis products by improving detection of pesticides and microbial contamination.…